Tell Me the Truth and I Will Not Be Harmed: Informed Consents and Nocebo Effects.
作者信息
Colloca Luana
机构信息
a University of Maryland , Baltimore.
出版信息
Am J Bioeth. 2017 Jun;17(6):46-48. doi: 10.1080/15265161.2017.1314057.
Abstract
摘要
相似文献
1
Tell Me the Truth and I Will Not Be Harmed: Informed Consents and Nocebo Effects.告诉我真相，我就不会受到伤害：知情同意与反安慰剂效应。
Am J Bioeth. 2017 Jun;17(6):46-48. doi: 10.1080/15265161.2017.1314057.
2
The Nocebo Effect and Informed Consent-Taking Autonomy Seriously.反安慰剂效应与知情同意——认真对待自主原则
Camb Q Healthc Ethics. 2020 Apr;29(2):223-235. doi: 10.1017/S0963180119001026.
3
The nocebo effect of informed consent.知情同意的反安慰剂效应。
Bioethics. 2014 Mar;28(3):147-54. doi: 10.1111/j.1467-8519.2012.01983.x. Epub 2012 Jul 5.
4
Commentary: Harm, Truth, and the Nocebo Effect.评论：伤害、真相与反安慰剂效应。
Camb Q Healthc Ethics. 2020 Apr;29(2):236-245. doi: 10.1017/S0963180119001038.
5
[Nocebo effects with the informed consent].[有知情同意情况下的反安慰剂效应]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2015 Jan;50(1):64-9. doi: 10.1055/s-0040-100081. Epub 2015 Jan 29.
6
Informed consent. Tell me honestly.知情同意。诚实地告诉我。
Nurs Times. 1986;82(21):25-6.
7
Unethical informed consent caused by overlooking poorly measured nocebo effects.因忽视测量不佳的反安慰剂效应而导致的不道德知情同意。
J Med Ethics. 2021 Sep;47(9):590-594. doi: 10.1136/medethics-2019-105903. Epub 2020 Feb 16.
8
Nocebo and informed consent in the internet era.互联网时代的反安慰剂效应与知情同意
Am J Bioeth. 2012;12(3):31-3. doi: 10.1080/15265161.2011.652801.
9
Saying things the "right" way: avoiding "nocebo" effects and providing full informed consent.以“正确”的方式表达：避免“反安慰剂”效应并提供充分的知情同意。
Am J Bioeth. 2012;12(3):33-4. doi: 10.1080/15265161.2012.656799.
10
Preventing Nocebo Effects of Informed Consent Without Paternalism.在不采取家长式作风的情况下防止知情同意中的反安慰剂效应。
Am J Bioeth. 2017 Jun;17(6):44-46. doi: 10.1080/15265161.2017.1314056.
引用本文的文献
1
What should constitute a control condition in psychedelic drug trials?在迷幻药试验中，什么应构成对照条件？
Nat Ment Health. 2024 Oct;2(10):1152-1160. doi: 10.1038/s44220-024-00321-2. Epub 2024 Sep 30.
2
Identifying the psychological effects of nocebo education: results from two pre-registered experiments.识别反安慰剂教育的心理效应：两项预先注册实验的结果。
J Behav Med. 2024 Dec;47(6):1080-1093. doi: 10.1007/s10865-024-00520-3. Epub 2024 Sep 21.
3
The Nocebo Effect.反安慰剂效应。
Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:171-190. doi: 10.1146/annurev-pharmtox-022723-112425. Epub 2023 Aug 16.
4
Avoidance of nocebo effects by coincident naming of treatment benefits during the medical interview for informed consent-Evidence from dynamometry.在用于知情同意的医学问诊过程中，通过同时提及治疗益处来避免反安慰剂效应——握力测量的证据
Front Psychol. 2022 Aug 9;13:923044. doi: 10.3389/fpsyg.2022.923044. eCollection 2022.
5
Attitudes Toward a Pre-authorized Concealed Opioid Taper: A Qualitative Analysis of Patient and Clinician Perspectives.对预先授权的隐匿性阿片类药物减量的态度：患者和临床医生观点的定性分析
Front Psychiatry. 2022 Mar 24;13:820357. doi: 10.3389/fpsyt.2022.820357. eCollection 2022.
6
Nocebo Effects of Clinical Communication and Placebo Effects of Positive Suggestions on Respiratory Muscle Strength.临床沟通的反安慰剂效应及积极暗示对呼吸肌力量的安慰剂效应
Front Psychol. 2022 Mar 11;13:825839. doi: 10.3389/fpsyg.2022.825839. eCollection 2022.
7
Veteran engagement in opioid tapering research: a mission to optimize pain management.退伍军人参与阿片类药物减量研究：优化疼痛管理的使命。
Pain Rep. 2021 Jun 3;6(2):e932. doi: 10.1097/PR9.0000000000000932. eCollection 2021 Jul-Aug.
8
Patient and Provider Acceptability of a Patient Preauthorized Concealed Opioid Reduction.患者预先授权的隐藏阿片类药物减量的患者和提供者可接受性。
Pain Med. 2021 Jul 25;22(7):1651-1659. doi: 10.1093/pm/pnaa454.
9
Placebo and nocebo phenomena in anti- CGRP monoclonal antibody trials for migraine prevention: a meta-analysis.安慰剂和反 CGRP 单克隆抗体试验中偏头痛预防的厌恶现象：荟萃分析。
J Neurol. 2020 Apr;267(4):1158-1170. doi: 10.1007/s00415-019-09673-7. Epub 2020 Jan 9.
10
The Clinical Implications of Nocebo Effects for Biosimilar Therapy.无安慰剂效应在生物类似药治疗中的临床意义。
Front Pharmacol. 2019 Nov 29;10:1372. doi: 10.3389/fphar.2019.01372. eCollection 2019.
本文引用的文献
1
Nocebo effects in clinical studies: hints for pain therapy.临床研究中的反安慰剂效应：疼痛治疗的启示
Pain Rep. 2017 Mar-Apr;2(2). doi: 10.1097/PR9.0000000000000586. Epub 2017 Jan 26.
2
Nocebo and pain: An overview of the psychoneurobiological mechanisms.反安慰剂效应与疼痛：心理神经生物学机制概述
Pain Rep. 2017 Mar-Apr;2(2). doi: 10.1097/PR9.0000000000000585.
3
When Respecting Autonomy Is Harmful: A Clinically Useful Approach to the Nocebo Effect.当尊重自主权会造成伤害时：一种对反安慰剂效应具有临床实用价值的方法。
Am J Bioeth. 2017 Jun;17(6):36-42. doi: 10.1080/15265161.2017.1314042.
4
Patient attitudes about the clinical use of placebo: qualitative perspectives from a telephone survey.患者对安慰剂临床应用的态度：电话调查的定性观点
BMJ Open. 2016 Apr 4;6(4):e011012. doi: 10.1136/bmjopen-2015-011012.
5
Patient autonomy and provider beneficence are compatible.患者自主权与医疗服务提供者的善行是相容的。
Hastings Cent Rep. 2013 Nov-Dec;43(6):6. doi: 10.1002/hast.222.
6
Nocebo effects, patient-clinician communication, and therapeutic outcomes.反安慰剂效应、医患沟通与治疗效果。
JAMA. 2012 Feb 8;307(6):567-8. doi: 10.1001/jama.2012.115.
7
The nocebo effect and its relevance for clinical practice.安慰剂效应及其与临床实践的相关性。
Psychosom Med. 2011 Sep;73(7):598-603. doi: 10.1097/PSY.0b013e3182294a50. Epub 2011 Aug 23.
8
The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment.安慰剂现象与医学伦理：重新思考知情同意与风险效益评估的关系。
Theor Med Bioeth. 2011 Aug;32(4):229-43. doi: 10.1007/s11017-011-9179-8.
9
When words are painful: unraveling the mechanisms of the nocebo effect.当言语带来痛苦时：解析反安慰剂效应的机制
Neuroscience. 2007 Jun 29;147(2):260-71. doi: 10.1016/j.neuroscience.2007.02.020. Epub 2007 Mar 26.
Zotero 插件